The importance of achieving additional drug benefits at a reasonable cost. A review of the fluoxetine years.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2000 AND VI 17 AND IP 4
Results: 9
1
2
Cost effectiveness of combination HIV therapy: 3 years later.
- Published in:
- 2000
- By:
- Publication type:
- journal article
3
Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures.
- Published in:
- 2000
- By:
- Publication type:
- journal article
4
Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.
- Published in:
- 2000
- By:
- Publication type:
- journal article
5
Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine.
- Published in:
- PharmacoEconomics, 2000, v. 17, n. 4, p. 351, doi. 10.2165/00019053-200017040-00005
- By:
- Publication type:
- Article
6
Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acid.
- Published in:
- 2000
- By:
- Publication type:
- journal article
7
Initial treatment choice in depression: impact on medical expenditures.
- Published in:
- 2000
- By:
- Publication type:
- journal article
8
Cost analysis of the treatment of schizophrenia in the UK. A simulation model comparing olanzapine, risperidone and haloperidol.
- Published in:
- 2000
- By:
- Publication type:
- journal article
9
Cost effectiveness of competing strategies to prevent or treat GORD-related dysphagia.
- Published in:
- 2000
- By:
- Publication type:
- journal article